New award for mometasone furoate nasal spray with golden state medical supply, INC. Ordering period is 1/27/2023 - 1/26/2024 with four one-year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79722D0032
- Awardee
-
Golden State Medical Supply, Inc. UEI GQLDJJ8AQNN5 Part of Gsms Inc.
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Mometasone Nasal Spray Pre-Solicitation · 36E79722R0028 · Posted Jun 28, 2022
- Last date to order 100% complete
- IDV ceiling
- $5,792,623.20
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Golden State Medical Supply, Inc. was awarded a single-award Indefinite Delivery Contract by the Veterans Affairs National Acquisition Center on January 27, 2023, for the supply of Mometasone Furoate Nasal Spray. The contract carries a ceiling value of $5,792,623.20 with an initial ordering period from January 27, 2023, through January 26, 2024, followed by four one-year option periods. The contract structure reflects a standard pharmaceutical prime vendor model designed to provide uninterrupted supply of this nasal corticosteroid medication to the Veterans Health Administration and other federal healthcare facilities. No set-aside designation was utilized for this procurement, indicating the award resulted from open competition. The award was derived from a pre-solicitation opportunity posted on June 28, 2022, with a submission deadline of July 8, 2022.
The government elected not to exercise the third option year with Golden State Medical Supply, Inc., resulting in a final contract expiration date of January 26, 2026. Mometasone Furoate Nasal Spray, a prescription-strength intranasal corticosteroid, represents a critical pharmaceutical supply item for managing allergic rhinitis and other nasal inflammatory conditions within the Department of Veterans Affairs healthcare system. This IDV award aligns with the Veterans Affairs National Acquisition Center's pharmaceutical supply chain strategy, which leverages single-award indefinite delivery contracts to ensure stable pricing, reliable product availability, and streamlined procurement processes for essential medications across the Veterans Integrated Service Network facilities nationwide.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79722D0032?
36E79722D0032 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on January 27, 2023.
How much is contract 36E79722D0032 worth?
36E79722D0032's own ceiling is $5,792,623.
Who can order from contract 36E79722D0032?
36E79722D0032 is a single award indefinite delivery contract.
Was contract 36E79722D0032 competed?
The extent of competition for 36E79722D0032 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV